Global Gene’s RARE Patient Advocacy Summit is the world’s largest gathering of rare disease patients, caregivers, thought leaders and stakeholders.
Today, CLSA applauded the U.S. House passage of H.R. 184, the Protect Medical Innovation Act, which permanently repeals the job and innovation hindering 2.3% medical device excise tax levied on medical technology companies.
After months of planning, San Francisco State University’s (SFSU) College of Business will launch its MBA program for Biotech Professionals in South San Francisco. Classes begin January 2018 and will take place two nights per week in the City Hall Building in downtown South San Francisco. SFSU is hosting an information session for biotech professionals … Continue reading SFSU Launches MBA Program for Biotech Professionals in SSF
Three Bay Area schools have received $20,000 each to expand science programming in their schools in a competition promoted by KNBR, CLSA and CLSI. Schools were asked to submit a brief application and video explaining how their school science programs would benefit from the grant funding. The grants were awarded in three geographic areas: … Continue reading Giants of Science Winners Announced!
The California Life Sciences Institute is pleased to announce the launch a new Innovation Series that will focus on issues most pressing for life science startups. The first Innovation panel – Reimbursement 101 – will take place on October 24 from 5:00 – 8:00 pm at Verily in South San Francisco. Moderated by Jessica Holmes, … Continue reading CLSI Launches Innovation Series with Reimbursement Panel at Verily
CLSA’s Brett Johnson, Senior Director of Policy and Regulatory Affairs, was featured on KSRO 103.5 FM/1350 AM Sharing Life Sciences Sector Concerns With SB 17.
To view the original article, click here. “This was a well-organized and executed event to help introduce and educate prospective applicants on the CARB-X funding mechanism. Including two guest speakers from exemplary programs funded by CARB-X provided great value to better understand the process and type of science being targeted. The additional opportunity to network … Continue reading CARB-X Brings the San Diego AMR Community Together-Testimonials
CLSA Pres. & CEO Sara Radcliffe pens an op-ed in The San Diego Union-Tribune on the strength of California and San Diego’s life sciences industry, the importance of BIO 2017 coming to San Diego, importance of policymakers and stakeholders to sustain and nurture growth of the sector.
Elections in the Bay Area’s Counties and Cities have their mark on the local landscape.